Warfarin treatment of a patient with coagulation factor IX propeptide mutation causing warfarin hypersensitivity-Reference-Cited by-同舟云学术

Warfarin treatment of a patient with coagulation factor IX propeptide mutation causing warfarin hypersensitivity

Published:2002-10-01 Issue:7 Volume:100 Page:2676-2676
ISSN:1528-0020
Container-title:Blood
language:en
Short-container-title:

Author:

Kristensen Søren Risom¹

Affiliation:

1. Correspondence: Søren Risom Kristensen, Department of Clinical Biochemistry and Genetics, Odense University Hospital, University of Southern Denmark, Odense, Denmark; e-mail:

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/100/7/2676/1254307/h81902002672d.pdf

Reference6 articles.

1. A mutation in the propeptide of factor IX leads to warfarin sensitivity by a novel mechanism.;Chu;J Clin Invest.,1996

2. Missense mutations at ALA-10 in the factor IX propeptide: an insignificant variant in normal life but a decisive cause of bleeding during oral anticoagulant therapy.;Oldenburg;Br J Haematol.,1997

3. Genetic predisposition to bleeding during oral anticoagulant therapy: evidence for common founder mutations (FIXVal-10 and FIX Thr-10) and an independent CpG hotspot mutation (FIXThr-10).;Oldenburg;Thromb Haemost.,2001

4. Seltene Ursache einer schweren Weichteileinblutung unter therapie mit Phenprocoumon.;Neuhaus;Dtsch Med Wochenschr.,2001

5. Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases.;Goodnough;Medicine.,1983

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factor IX p.A37V mutation causes severe bleeding in a patient with phenprocoumon therapy;European Journal of Medical Research;2021-06-29

2. The Conundrum of “Warfarin Hypersensitivity”;American Journal of Therapeutics;2016-05

3. Comparative genetics of warfarin resistance;Hämostaseologie;2014

4. Coagulation factor IX；its molecular structure and functional mechanism;Japanese Journal of Thrombosis and Hemostasis;2013

5. Life-threatening bleeding under vitamin K antagonists in spite of an INR in the therapeutic range;Journal of Thrombosis and Thrombolysis;2011-03-18